跳至主要内容
临床试验/DRKS00004641
DRKS00004641已完成未知

Prospective multicenter study for functional evaluation of transoral laser microsurgery (TLM) for supraglottic carcinomas - SUPRATOL - SUPRATO

niversitätsklinikum Schleswig-Holstein Campus Kiel0 个研究点目标入组 102 人开始时间: 2015年2月24日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
102

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
N/a: Single Arm Study
盲法
Open (masking not used)

入排标准

年龄范围
18 Years 至 one(—)
性别
All

入选标准

  • Histologically proven squamous cell carcinoma of the supraglottic larynx
  • T2 and T3 tumor (UICC, 7th edition 2010)
  • Stage II-IVb (UICC, 7th edition 2010)
  • Age =18 years
  • No pregnancy, reliable contraception during time of treatment
  • Written informed consent
  • Examination of swallowing function by FEES possible

排除标准

  • Tumor location outside the supraglottic larynx
  • R0 resection of cervical lymph node metastases not possible
  • Simultaneous distant metastases
  • Simultaneous second primary tumor
  • Previous malignant tumor, except basalioma and spinalioma of the skin and carcinomata in situ.
  • Malignant tumor in patient’s history with follow-up time less than 5 years. Patients without relapse within 5 years after therapy of a malignant tumor need consultation with the Principal Investigator.
  • Previous local, regional or systemic tumor therapy.
  • No suitability for general anesthesia.
  • Not tumor-related swallowing disorder.

研究者

发起方
niversitätsklinikum Schleswig-Holstein Campus Kiel

相似试验